About DOVATO

DOVATO is a prescription medication used to treat HIV-1 infection in adults and pediatric patients 4 weeks of age and older. It is a fixed-dose combination of dolutegravir sodium and lamivudine, two antiretroviral medications that work together to suppress the replication of the virus.

Key Benefits & Uses

Treatment of HIV-1 infection in adults and pediatric patients 4 weeks of age and older.
Combination therapy with other antiretroviral medications to suppress viral replication and maintain undetectable viral loads.
Part of a comprehensive treatment plan to manage HIV-1 infection and prevent disease progression.

Active Ingredient & Action

The active ingredients in DOVATO work together to inhibit the replication of HIV-1. Dolutegravir sodium is an integrase inhibitor that blocks the integration of viral DNA into the host cell's genome, while lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the replication of viral RNA.

Important Notes

DOVATO should be used under the guidance of a healthcare provider and as part of a comprehensive treatment plan. It is essential to follow the recommended dosage and administration instructions to ensure optimal efficacy and minimize the risk of side effects. Patients should also be aware of the potential for drug interactions and report any adverse reactions to their healthcare provider promptly.